Sevenless Therapeutics ApS
CVR 43311999 · Private limited company (ApS) · Active · Low risk
Sevenless Therapeutics ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.2 times the average for Danish companies. 4 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -645k and a net result of DKK -160k. CEO: Neil Benson, Alasdair Naylor, Alexander Robert Leech.
Bankruptcy risk for Sevenless Therapeutics ApS
0.2 × the average (1.41%) · higher risk than 49% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 43311999
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (4 years)
- Address
- Ole Maaløes Vej 3, 3.
2200 København N - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 4 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -5.2% |
| Current ratio | 3,683% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 167 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -197k | DKK -260k |
| Net profit | DKK -160k | DKK -597k |
| Equity | DKK -645k | DKK -485k |
| Total assets | DKK 12.4m | DKK 12.1m |
| Cash | DKK 435k | – |
| Short-term debt | DKK 28k | – |
| Avg. employees | 3 | – |
Latest annual report: Reporting class B · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 180 | ||
| 1 Jan 2024 – 31 Dec 2024 | 175 | ||
| 1 Jan 2023 – 31 Dec 2023 | 178 | ||
| 6 Jun 2022 – 31 Dec 2022 | 181 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Neil Benson | Current | |
| CEO | Alasdair Naylor | Current | |
| CEO | Alexander Robert Leech | Current | |
| Owner (100%) | Sevenless Therapeutics Limited | Current | |
| Founder | Sevenless Therapeutics Limited | Current |
Address history (0 moves)
| Ole Maaløes Vej 3, 3., 2200 København N |
Other companies at the same address
- 25-06-2019 ApS Bankrupt
- Ankrin Therapeutics ApS Bankrupt
- Avineuro ApS Bankrupt
- BIOREPELLER IVS Bankrupt
- Bainan Biotech ApS Bankrupt
- Broselid Holding IVS Bankrupt
- ChildTreat ApS Bankrupt
- Dencomm ApS Bankrupt
- IO BIOTECH ApS Bankrupt
- Invitreo Biosciences ApS Bankrupt
- Lab Hos Development ApS Bankrupt
- MGM BIO IVS Bankrupt
- Mind the Byte ApS Bankrupt
- PanCryos ApS Bankrupt
- Ressaissi Holding IVS Bankrupt
- SSIP 2023 ApS Bankrupt
- Spit Test Company ApS Bankrupt
- Sterisafe Holding A/S Bankrupt
- Sumondo ApS Bankrupt
- TychoBio IVS Bankrupt
- aiwell Nordic ApS Bankrupt
- 1stBiome ApS Active
- 3Sonic ApS Active
- 55 North General Partner I ApS Active
- 55 North Management ApS Active
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about Sevenless Therapeutics ApS
Has Sevenless Therapeutics ApS gone bankrupt?
No, Sevenless Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Sevenless Therapeutics ApS?
Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.
Who is the CEO of Sevenless Therapeutics ApS?
Neil Benson, Alasdair Naylor, Alexander Robert Leech are the CEOs of Sevenless Therapeutics ApS.
When was Sevenless Therapeutics ApS founded?
Sevenless Therapeutics ApS was founded on 6 June 2022.
What is the equity of Sevenless Therapeutics ApS?
Equity was DKK -645k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.